XTX Topco’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

XTX Topco’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-35,823	Closed	-$10.1K	–	3137
2024 Q3	$10.1K	Buy	35,823 +21,316	+147%	+$9.96K	﹤0.01%	1917
2024 Q2	$10.9K	Sell	14,507 -25,300	-64%	-$16.2K	﹤0.01%	1680
2024 Q1	$19.4K	Buy	39,807 +27,439	+222%	+$18.4K	﹤0.01%	1610
2023 Q4	$10.2K	Buy	12,368 +10,958	+777%	+$22.3K	﹤0.01%	1430
2023 Q3	$4.2K	Buy	+1,410	New	+$2.57K	﹤0.01%	1471

Other funds holding NVOS

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

XTX Topco's NVOS Position: Q4 2024 in Review

XTX Topco sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 35,823 shares — an estimated $10.1K sold.

XTX Topco first reported a position in NVOS in Q3 2023 and held it in 5 quarters. The position peaked at $19.4K in Q1 2024. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

XTX Topco reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
XTX Topco sold 35,823 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $10.1K.
XTX Topco first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
XTX Topco's Novo Integrated Sciences, Inc. Common Stock position peaked at $19.4K in Q1 2024.
1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on XTX Topco's 13F filing for Q4 2024, filed 13 Feb 2025.